文献速递神经肿瘤

犬(宠物狗)肿瘤显微手术与节拍性苯丁酸氮芥在自发性胶质瘤中的瘤内浓度及安全性:一项Ⅰ期临床试验

Canine (Pet Dog) Tumor Microsurgery and Intratumoral Concentration and Safety of Metronomic Chlorambucil for Spontaneous Glioma: A Phase I Clinical Trial.
PubMed 文献 · World Neurosurg · 2018-06-05

本研究前瞻性纳入8只新诊断自发性胶质瘤的宠物犬,术前每24小时给予4 mg/m²苯丁酸氮芥至少3天并术后持续给药,分析手术标本、脑脊液和血清药物浓度。中位瘤内浓度为0.52 ng/g(范围0-2.62 ng/g),为血清浓度的37%(范围0%-178%);中位无进展生存期253天,中位总生存期257天。作者认为该剂量下耐受良好,但用药前需进一步研究。

要点

  • 8只犬中7例少突胶质细胞瘤、1例星形细胞瘤,6例高级别、2例低级别,均实现完全显微手术切除。
  • 中位瘤内苯丁酸氮芥浓度0.52 ng/g(范围0-2.62 ng/g),为血清浓度的37%(范围0%-178%)。
  • 3只犬在用药8-12个月后出现无症状性血小板减少,未观察到肌阵挛,癫痫活动未增加。

核心结论

  • 瘤内苯丁酸氮芥的存在提示血脑屏障改变且个体间存在差异。
  • 尽管既往有零星神经毒性报告,延长的无癫痫发作间期支持该剂量在该物种中具有较高的安全边际。
  • 节拍性苯丁酸氮芥耐受良好,自发性犬胶质瘤提供了稳健的临床前模型。
  • 在用于人类胶质瘤患者之前,节拍性苯丁酸氮芥仍需进一步研究。

研究设计与样本

  • 前瞻性Ⅰ期临床试验,纳入8只客户拥有的新诊断自发性胶质瘤宠物犬。
  • 术前每24小时给予苯丁酸氮芥4 mg/m²至少3天,术后持续给药至死亡或出现剂量限制性不良事件。
  • 分析手术胶质瘤标本、脑脊液和血清中的苯丁酸氮芥浓度,术后另接受洛莫司汀治疗。
  • 监测癫痫发作、肌阵挛、血细胞减少和肿瘤复发。

主要发现

  • 7例少突胶质细胞瘤和1例星形细胞瘤(6例高级别,2例低级别)实现完全显微手术切除。
  • 中位手术胶质瘤标本苯丁酸氮芥浓度为0.52 ng/g(范围0-2.62 ng/g),为血清浓度的37%(范围0%-178%)。
  • 中位脑脊液浓度为0.1 ng/mL(范围0-0.3 ng/mL)。
  • 苯丁酸氮芥与癫痫活动增加无关,6只犬显示延长的无癫痫发作间期,未出现肌阵挛。
  • 3只犬在苯丁酸氮芥治疗8-12个月后出现无症状性血小板减少。

临床怎么用

  • 作者认为,尽管既往有零星神经毒性报告,延长的无癫痫发作间期支持该剂量在该物种中具有较高的安全边际。
  • 作者指出,节拍性苯丁酸氮芥在用于人类胶质瘤患者之前仍需进一步研究。
  • 作者认为自发性犬胶质瘤提供了稳健的临床前模型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Metronomic (daily low-dose) chlorambucil requires further study before use in human patients with glioma. The aim of this study was to investigate distribution and safety of metronomic chlorambucil in naturally occurring canine glioma. METHODS: Eight client-owned (pet) dogs with newly diagnosed spontaneous glioma were prospectively enrolled. Chlorambucil was administered preoperatively at 4 mg/m2 every 24 hours for ≥3 days and continued postoperatively until death or dose-limiting adverse events. Chlorambucil concentrations in the surgical glioma specimen, cerebrospinal fluid, and serum were analyzed. Dogs additionally received lomustine postoperatively. Dogs were monitored for seizures, myoclonus, cytopenias, and tumor recurrence. RESULTS: Complete microsurgical resection was achieved in 7 oligodendrogliomas and 1 astrocytoma (6 high grade, 2 low grade). Median surgical glioma specimen chlorambucil concentration was 0.52 ng/g (range, 0-2.62 ng/g), or 37% (range, 0%-178%) of serum concentration. Median cerebrospinal fluid concentration was 0.1 ng/mL (range, 0-0.3 ng/mL). Chlorambucil was not associated with increase in seizure activity. Six dogs displayed prolonged seizure-free intervals. There was no myoclonus. Three dogs developed asymptomatic thrombocytopenia after 8-12 months of chlorambucil. Median progression-free survival was 253 days (range, 63-860 days). Median overall survival was 257 days (range, 64-860 days). CONCLUSIONS: The presence of intratumoral chlorambucil indicated an altered blood-brain barrier that varied from case to case. Despite sporadic previous reports of neurotoxicity, prolonged seizure-free intervals supported a high safety margin at this dose in this species. Metronomic chlorambucil was well tolerated. Spontaneous canine glioma offers a robust preclinical model.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bentley RT, Thomovsky SA, Miller MA, et al. Canine (Pet Dog) Tumor Microsurgery and Intratumoral Concentration and Safety of Metronomic Chlorambucil for Spontaneous Glioma: A Phase I Clinical Trial. World Neurosurg. 2018. PMID: 29775768. doi:10.1016/j.wneu.2018.05.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。